Home Capital Broker's Calls

Singapore Medical Group growing stronger with string of acquisitions

Jude Chan
Jude Chan4/24/2017 11:44 AM GMT+08  • 2 min read
Singapore Medical Group growing stronger with string of acquisitions
SINGAPORE (April 24): RHB Research is keeping its “buy” recommendation on Singapore Medical Group (SMG) with a higher target price of 79 cents, from 65 cents previously.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (April 24): RHB Research is keeping its “buy” recommendation on Singapore Medical Group (SMG) with a higher target price of 79 cents, from 65 cents previously.

This comes after SMG recently announced the acquisition of two paediatric clinics in Toa Payoh and Bishan for $25.3 million, as well as an additional 10% stake in its subsidiary, The Cancer Centre, for $2.9 million.

SMG is “rapidly expanding into a sizable specialist group” on the back of “a string of acquisitions locally, in various medical streams like imaging diagnostics, O&G, as well as paediatrics in the past 12 months,” says RHB analyst Jarick Seet in a Monday report.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.